세계의 헬스케어 컨설팅 서비스 시장 예측(-2030년) : 서비스 유형별, 최종사용자별, 지역별

The healthcare consulting services market is projected to reach USD 51.95 billion by 2030 from USD 32.17 billion in 2025, at a CAGR of 10.1% during the forecast period. The growing demand for adopting electronic health records, telehealth, and AI-driven diagnostics, along with the shift toward value-based care and operational cost pressures, is driving demand for expert advisory services. Additionally, expanding healthcare infrastructure in emerging markets and innovation in pharma and MedTech fuel market growth.

By service type, the IT & digital transformation consulting services segment is expected to dominate the market during the forecast period.

By service type, the healthcare consulting services market is segmented into IT & digital transformation consulting services; strategy consulting services; operation consulting services; financial consulting services; HR & talent consulting services; marketing, sales, and commercialization consulting services; regulatory & compliance; R&D consulting services; public health consulting services; and other services. The highest growth rate of the IT & digital transformation consulting services segment is attributed to the increasing adoption of electronic health records (EHRs) and telemedicine platforms; the utilization of AI for diagnostics & operations; the importance of cloud computing; and the advancement of cybersecurity solutions.

By end user, the pharmaceutical & biotechnology companies segment accounted for the largest market share in 2024.

The healthcare consulting services market is segmented by end users into government bodies, healthcare providers, health insurance payers, pharmaceutical & biotechnological companies, medical device companies, and other end users. The pharmaceutical & biotechnological companies segment accounted for the largest market share in 2024. This dominance is driven by their growing need for cost optimization in API operations, formulation development, and supply chain management. These companies also face complex and frequently changing regulatory requirements, necessitating expert guidance on compliance, mergers and acquisitions, product launch strategies, and brand management.

By region, North America accounted for the largest market share in 2024.

The global healthcare consulting services market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest market share. The large share of this segment is attributed to the highly developed healthcare infrastructure, substantial healthcare spending, widespread adoption of digital health technologies, and strong regulatory frameworks. The presence of leading healthcare consulting firms, advanced payer-provider models, and continuous investment in value-based care, AI, and patient experience further reinforces North America's leadership in the sector.

The breakdown of primary participants is as mentioned below:

• By Company Type - Tier 1 (31%), Tier 2 (28%), and Tier 3 (41%)
• By Designation - C-level Executives (31%), Director-level (25%), and Managers (44%)
• By Region - North America (45%), Europe (28%), the Asia Pacific (20%), Latin America (4%), and the Middle East & Africa (3%)

Key Players

The prominent players in this market are Accenture Plc (Ireland), Cognizant Technology Solutions Corporation (US), Deloitte (UK), McKinsey & Company (UK), PwC (UK), Ernst & Young Global Limited (EY) (UK), Huron Consulting Group Inc. (US), and KPMG (UK), among others.

Research Coverage

• The report studies the healthcare consulting services market based on service type, end user, and region.
• The report analyzes factors (drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the market's opportunities and challenges for stakeholders and details the competitive landscape for market leaders.
• The report studies micro-markets regarding their growth trends, prospects, and contributions to the total healthcare consulting services market.
• The report forecasts the revenue of market segments in five regions.

Reasons to Buy the Report

The report can help established and new entrants/smaller firms gauge the market's pulse, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the five strategies mentioned below.

This report provides insights into the following pointers:

• Analysis of key drivers (Growing rate of digitization in healthcare, Increasing adoption of big data analytics, IoT, and cloud deployment in the healthcare industry, changing healthcare landscape with respect to regulatory compliance and technological evolution, decreasing number of in-house experts in the end-use industries, rising level of government support for HCIT solutions, growing need for structural changes and new business models in the healthcare industry, increasing number of patients suffering from various chronic and infectious diseases, and increasing pressure to reduce the rising healthcare costs), restraints (rising number of concerns regarding data confidentiality, increasing number of hidden costs of consulting services), opportunities (growing demand for cloud consulting, increasing potential for healthcare consulting services in the emerging markets, increasing consolidation in the healthcare industry), and challenges (rising number of multi-sourcing approaches, high cost of consulting services) influencing the growth of the healthcare consulting services market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the healthcare consulting services market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various healthcare consulting services solutions across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the Healthcare consulting services market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the healthcare consulting services market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 SUPPLY-SIDE ANALYSIS
  • 2.2.2 BOTTOM-UP APPROACH
  • 2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
  • 2.2.4 GROWTH FORECAST
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
  • 2.4.1 PARAMETRIC ASSUMPTIONS
  • 2.4.2 STUDY-RELATED ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
  • 2.5.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.5.2 SCOPE-RELATED LIMITATIONS
• 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 HEALTHCARE CONSULTING SERVICES MARKET OVERVIEW
• 4.2 ASIA PACIFIC HEALTHCARE CONSULTING SERVICES MARKET, BY COUNTRY AND END USER
• 4.3 HEALTHCARE CONSULTING SERVICES MARKET: REGIONAL GROWTH OPPORTUNITIES
• 4.4 HEALTHCARE CONSULTING SERVICES MARKET: REGIONAL MIX
• 4.5 HEALTHCARE CONSULTING SERVICES MARKET: EMERGING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing trend of digitization
    • 5.2.1.2 Increasing adoption of big data analytics, IoT, and cloud deployment
    • 5.2.1.3 Changing healthcare landscape
    • 5.2.1.4 Rising government support for HCIT solutions
    • 5.2.1.5 Emergence of new business models
    • 5.2.1.6 Growing incidence of chronic and infectious diseases
    • 5.2.1.7 Need for data security
    • 5.2.1.8 Increasing pressure to reduce healthcare costs
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Data confidentiality concerns
    • 5.2.2.2 Hidden costs of consulting services
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rising trend of consolidation
    • 5.2.3.2 Opportunities in emerging markets
    • 5.2.3.3 Consistent rise in mergers and acquisitions
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Rising number of multi-sourcing approaches
• 5.3 INDUSTRY TRENDS
  • 5.3.1 DIGITAL TRANSFORMATION IN HEALTHCARE
  • 5.3.2 SHIFT TOWARD VALUE-BASED CARE
  • 5.3.3 FOCUS ON PATIENT-CENTRIC CARE
  • 5.3.4 RISING IMPORTANCE OF SOCIAL DETERMINANTS OF HEALTH
  • 5.3.5 EXPANDING USE OF DATA ANALYTICS
  • 5.3.6 GROWTH OF PRECISION MEDICINE
• 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.5 INDICATIVE PRICING ANALYSIS
  • 5.5.1 INDICATIVE PRICING ANALYSIS, BY TYPE OF SERVICE
  • 5.5.2 INDICATIVE PRICING ANALYSIS, BY REGION
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Machine learning
    • 5.9.1.2 Artificial intelligence
    • 5.9.1.3 Cloud computing
    • 5.9.1.4 Big data and advanced analytics
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
    • 5.9.2.1 Robotic Process Automation (RPA)
    • 5.9.2.2 Natural Language Processing (NLP)
  • 5.9.3 ADJACENT TECHNOLOGIES
    • 5.9.3.1 Blockchain
    • 5.9.3.2 Internet of Things (IoT)
• 5.10 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.11 CASE STUDY ANALYSIS
  • 5.11.1 ENHANCED PATIENT EXPERIENCE WITH PAPERLESS PROCESS
  • 5.11.2 ADVANCED CLOUD SOLUTION TO IMPROVE HUMAN CAPITAL MANAGEMENT CAPABILITIES
  • 5.11.3 DEVELOPMENT OF RISK MANAGEMENT PLANS FOR EFFECTIVE TREATMENT
• 5.12 REGULATORY LANDSCAPE
  • 5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.12.2 REGULATORY ANALYSIS
    • 5.12.2.1 North America
    • 5.12.2.2 Europe
    • 5.12.2.3 Asia Pacific
    • 5.12.2.4 Middle East & Africa
    • 5.12.2.5 Latin America
• 5.13 PORTER'S FIVE FORCES ANALYSIS
  • 5.13.1 BARGAINING POWER OF SUPPLIERS
  • 5.13.2 BARGAINING POWER OF BUYERS
  • 5.13.3 THREAT OF NEW ENTRANTS
  • 5.13.4 THREAT OF SUBSTITUTES
  • 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.14.2 BUYING CRITERIA
• 5.15 BUSINESS MODELS
• 5.16 IMPACT OF 2025 US TARIFF
  • 5.16.1 INTRODUCTION
  • 5.16.2 KEY TARIFF RATES
  • 5.16.3 PRICE IMPACT ANALYSIS
  • 5.16.4 IMPACT ON COUNTRY/REGION
    • 5.16.4.1 US
    • 5.16.4.2 Europe
    • 5.16.4.3 Asia Pacific
  • 5.16.5 IMPACT ON END-USE INDUSTRIES

6 HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE

• 6.1 INTRODUCTION
• 6.2 IT/DIGITAL TRANSFORMATION CONSULTING
  • 6.2.1 RISING DEMAND FOR MODERNIZATION AND VALUE-BASED CARE DELIVERY TO AID GROWTH
• 6.3 STRATEGY CONSULTING
  • 6.3.1 RAPID TECHNOLOGICAL ADVANCEMENTS TO FACILITATE GROWTH
• 6.4 OPERATIONS CONSULTING
  • 6.4.1 TRANSITION FROM FEE-FOR-SERVICE TO COORDINATED CARE MODEL TO SUSTAIN GROWTH
• 6.5 FINANCIAL CONSULTING
  • 6.5.1 RISING NEED FOR OPTIMIZED REVENUE CYCLE MANAGEMENT TO STIMULATE GROWTH
• 6.6 HR & TALENT CONSULTING
  • 6.6.1 ONGOING SHORTAGE OF HEALTHCARE PROFESSIONALS TO PROMOTE GROWTH
• 6.7 MARKETING, SALES, AND COMMERCIALIZATION CONSULTING
  • 6.7.1 INNOVATIONS IN DRUG DEVELOPMENT AND MEDICAL TECHNOLOGY TO DRIVE MARKET
• 6.8 REGULATORY & COMPLIANCE
  • 6.8.1 RAPID ADOPTION OF DIGITAL HEALTH TECHNOLOGIES TO AUGMENT GROWTH
• 6.9 R&D CONSULTING
  • 6.9.1 GROWING DEMAND FOR NEW DRUGS TO BOOST MARKET
• 6.10 PUBLIC HEALTH CONSULTING
  • 6.10.1 INCREASING INVESTMENTS IN PUBLIC HEALTH INFRASTRUCTURE TO FOSTER GROWTH
• 6.11 OTHER CONSULTING SERVICES

7 HEALTHCARE CONSULTING SERVICES MARKET, BY END USER

• 7.1 INTRODUCTION
• 7.2 GOVERNMENT BODIES
  • 7.2.1 GROWING INVESTMENTS IN MODERNIZING DIGITAL AND TECHNOLOGY INFRASTRUCTURE TO FUEL MARKET
• 7.3 HEALTHCARE PROVIDERS
  • 7.3.1 HOSPITALS
    • 7.3.1.1 Growing need for telehealth and remote care to propel market
  • 7.3.2 AMBULATORY CARE CENTERS
    • 7.3.2.1 Rising demand for convenient and patient-centered services to bolster growth
  • 7.3.3 LONG-TERM CARE FACILITIES
    • 7.3.3.1 Booming geriatric population to contribute to growth
  • 7.3.4 DIAGNOSTIC & IMAGING CENTERS
    • 7.3.4.1 Rising global demand for early disease detection, precision diagnostics, and outpatient imaging services to favor growth
  • 7.3.5 OTHER HEALTHCARE PROVIDERS
• 7.4 HEALTH INSURANCE PAYERS
  • 7.4.1 PRIVATE PAYERS
    • 7.4.1.1 Need for regulatory compliance to encourage growth
  • 7.4.2 PUBLIC PAYERS
    • 7.4.2.1 Growing digital transformation initiatives to boost market
• 7.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 7.5.1 EVOLVING LIFE SCIENCES LANDSCAPE TO SPUR GROWTH
• 7.6 MEDICAL DEVICE COMPANIES
  • 7.6.1 GROWING FOCUS OF MEDICAL DEVICE COMPANIES ON CUTTING-EDGE TECHNOLOGY TO DRIVE MARKET
• 7.7 OTHER END USERS

8 HEALTHCARE CONSULTING SERVICES MARKET, BY REGION

• 8.1 INTRODUCTION
• 8.2 NORTH AMERICA
  • 8.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 8.2.2 US
    • 8.2.2.1 Advanced infrastructure and high healthcare spending to augment growth
  • 8.2.3 CANADA
    • 8.2.3.1 Shift toward technology-driven integrated healthcare model to spur growth
• 8.3 EUROPE
  • 8.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 8.3.2 GERMANY
    • 8.3.2.1 Increasing emphasis on electronic documentation and compliance to spur growth
  • 8.3.3 UK
    • 8.3.3.1 Need for sectoral restructuring to accelerate growth
  • 8.3.4 FRANCE
    • 8.3.4.1 Need to ensure interoperability and compatibility among healthcare IT systems to aid growth
  • 8.3.5 ITALY
    • 8.3.5.1 Expansion of digital health sector to support growth
  • 8.3.6 SPAIN
    • 8.3.6.1 Growing digitization of healthcare systems to boost market
  • 8.3.7 REST OF EUROPE
• 8.4 ASIA PACIFIC
  • 8.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 8.4.2 JAPAN
    • 8.4.2.1 Increasing adoption of information technology in medical care and home nursing to promote growth
  • 8.4.3 CHINA
    • 8.4.3.1 Favorable government initiatives to bolster growth
  • 8.4.4 INDIA
    • 8.4.4.1 Growing adoption of connected healthcare ecosystem to boost market
  • 8.4.5 REST OF ASIA PACIFIC
• 8.5 LATIN AMERICA
  • 8.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 8.5.2 BRAZIL
    • 8.5.2.1 Ongoing efforts to modernize healthcare infrastructure to promote growth
  • 8.5.3 MEXICO
    • 8.5.3.1 Rising healthcare costs to contribute to growth
  • 8.5.4 REST OF LATIN AMERICA
• 8.6 MIDDLE EAST & AFRICA
  • 8.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 8.6.2 GCC COUNTRIES
    • 8.6.2.1 Increasing investments in healthcare infrastructure to contribute to growth
  • 8.6.3 REST OF MIDDLE EAST & AFRICA

9 COMPETITIVE LANDSCAPE

• 9.1 OVERVIEW
• 9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE CONSULTING SERVICES MARKET
• 9.3 REVENUE ANALYSIS, 2020-2024
• 9.4 MARKET SHARE ANALYSIS, 2024
• 9.5 COMPANY VALUATION AND FINANCIAL METRICS
• 9.6 BRAND/SOFTWARE COMPARISON
• 9.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 9.7.1 STARS
  • 9.7.2 EMERGING LEADERS
  • 9.7.3 PERVASIVE PLAYERS
  • 9.7.4 PARTICIPANTS
  • 9.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 9.7.5.1 Company footprint
    • 9.7.5.2 Region footprint
    • 9.7.5.3 Type of service footprint
    • 9.7.5.4 End-user footprint
• 9.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 9.8.1 PROGRESSIVE COMPANIES
  • 9.8.2 RESPONSIVE COMPANIES
  • 9.8.3 DYNAMIC COMPANIES
  • 9.8.4 STARTING BLOCKS
  • 9.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 9.8.5.1 Detailed list of key startups/SMEs
    • 9.8.5.2 Competitive benchmarking of key startups/SMEs
• 9.9 COMPETITIVE SCENARIO
  • 9.9.1 PRODUCT LAUNCHES
  • 9.9.2 DEALS
  • 9.9.3 EXPANSIONS
  • 9.9.4 OTHER DEVELOPMENTS

10 COMPLNY PROFILE

• 10.1 KEY PLAYERS
  • 10.1.1 ACCENTURE
    • 10.1.1.1 Business overview
    • 10.1.1.2 Products/Services/Solutions offered
    • 10.1.1.3 Recent developments
      • 10.1.1.3.1 Deals
    • 10.1.1.4 MnM view
      • 10.1.1.4.1 Key strengths
      • 10.1.1.4.2 Strategic choices
      • 10.1.1.4.3 Weaknesses and competitive threats
  • 10.1.2 COGNIZANT
    • 10.1.2.1 Business overview
    • 10.1.2.2 Products/Services/Solutions offered
    • 10.1.2.3 Recent developments
      • 10.1.2.3.1 Deals
      • 10.1.2.3.2 Expansions
    • 10.1.2.4 MnM view
      • 10.1.2.4.1 Key strengths
      • 10.1.2.4.2 Strategic choices
      • 10.1.2.4.3 Weaknesses and competitive threats
  • 10.1.3 DELOITTE
    • 10.1.3.1 Business overview
    • 10.1.3.2 Products/Services/Solutions offered
    • 10.1.3.3 Recent developments
      • 10.1.3.3.1 Product launches
      • 10.1.3.3.2 Deals
    • 10.1.3.4 MnM view
      • 10.1.3.4.1 Key strengths
      • 10.1.3.4.2 Strategic choices
      • 10.1.3.4.3 Weaknesses and competitive threats
  • 10.1.4 MCKINSEY & COMPANY
    • 10.1.4.1 Business overview
    • 10.1.4.2 Products/Services/Solutions offered
    • 10.1.4.3 Recent developments
      • 10.1.4.3.1 Product launches
    • 10.1.4.4 Recent developments
      • 10.1.4.4.1 Deals
    • 10.1.4.5 MnM view
      • 10.1.4.5.1 Key strengths
      • 10.1.4.5.2 Strategic choices
      • 10.1.4.5.3 Weaknesses and competitive threats
  • 10.1.5 BOSTON CONSULTING GROUP
    • 10.1.5.1 Business overview
    • 10.1.5.2 Products/Services/Solutions offered
    • 10.1.5.3 Recent developments
      • 10.1.5.3.1 Deals
    • 10.1.5.4 MnM view
      • 10.1.5.4.1 Key strengths
      • 10.1.5.4.2 Strategic choices
      • 10.1.5.4.3 Weaknesses and competitive threats
  • 10.1.6 PWC
    • 10.1.6.1 Business overview
    • 10.1.6.2 Products/Services/Solutions offered
    • 10.1.6.3 Recent developments
      • 10.1.6.3.1 Deals
  • 10.1.7 EY
    • 10.1.7.1 Business overview
    • 10.1.7.2 Products/Services/Solutions offered
    • 10.1.7.3 Recent developments
      • 10.1.7.3.1 Product launches
  • 10.1.8 HURON CONSULTING GROUP INC.
    • 10.1.8.1 Business overview
    • 10.1.8.2 Products/Services/Solutions offered
    • 10.1.8.3 Recent developments
      • 10.1.8.3.1 Deals
  • 10.1.9 KPMG
    • 10.1.9.1 Business overview
    • 10.1.9.2 Products/Services/Solutions offered
    • 10.1.9.3 Recent developments
      • 10.1.9.3.1 Product launches
      • 10.1.9.3.2 DEALS
  • 10.1.10 BAIN & COMPANY, INC.
    • 10.1.10.1 Business overview
    • 10.1.10.2 Products/Services/Solutions offered
    • 10.1.10.3 Recent developments
      • 10.1.10.3.1 Deals
  • 10.1.11 IQVIA INC.
    • 10.1.11.1 Business overview
    • 10.1.11.2 Products/Services/Solutions offered
    • 10.1.11.3 Recent developments
      • 10.1.11.3.1 Product launches
    • 10.1.11.4 Recent developments
      • 10.1.11.4.1 Deals
  • 10.1.12 L.E.K. CONSULTING
    • 10.1.12.1 Business overview
    • 10.1.12.2 Products/Services/Solutions offered
    • 10.1.12.3 Recent developments
      • 10.1.12.3.1 Deals
      • 10.1.12.3.2 Expansions
  • 10.1.13 NTT DATA, INC.
    • 10.1.13.1 Business overview
    • 10.1.13.2 Products/Services/Solutions offered
    • 10.1.13.3 Recent developments
      • 10.1.13.3.1 Product launches
      • 10.1.13.3.2 Deals
  • 10.1.14 OLIVER WYMAN, LLC
    • 10.1.14.1 Business overview
    • 10.1.14.2 Products/Services/Solutions offered
    • 10.1.14.3 Recent developments
      • 10.1.14.3.1 Product launches
      • 10.1.14.3.2 Deals
  • 10.1.15 SIMON-KUCHER & PARTNERS
    • 10.1.15.1 Business overview
    • 10.1.15.2 Products/Services/Solutions offered
  • 10.1.16 IBM
    • 10.1.16.1 Business overview
    • 10.1.16.2 Products/Services/Solutions offered
    • 10.1.16.3 Recent developments
      • 10.1.16.3.1 Product launches
      • 10.1.16.3.2 Deals
  • 10.1.17 CLEARVIEW HEALTHCARE PARTNERS
    • 10.1.17.1 Business overview
    • 10.1.17.2 Products/Services/Solutions offered
    • 10.1.17.3 Recent developments
      • 10.1.17.3.1 Other developments
  • 10.1.18 ALVAREZ & MARSAL HOLDINGS, LLC
    • 10.1.18.1 Business overview
    • 10.1.18.2 Products offered
    • 10.1.18.3 Recent developments
      • 10.1.18.3.1 Product launches
  • 10.1.19 ZS ASSOCIATES
    • 10.1.19.1 Business overview
    • 10.1.19.2 Products/Services/Solutions offered
    • 10.1.19.3 Recent developments
      • 10.1.19.3.1 Product launches
      • 10.1.19.3.2 Deals
  • 10.1.20 CHARTIS
    • 10.1.20.1 Business overview
    • 10.1.20.2 Products/Services/Solutions offered
    • 10.1.20.3 Recent developments
      • 10.1.20.3.1 Deals
• 10.2 OTHER PLAYERS
  • 10.2.1 QUALITY CREST HEALTHCARE CONSULTANTS PRIVATE LIMITED
  • 10.2.2 LUCID HEALTH CONSULTING
  • 10.2.3 BLUE MATTER CONSULTING
  • 10.2.4 ISOS CONSULTANCY SERVICES PVT. LTD.
  • 10.2.5 BACK BAY LIFE SCIENCE ADVISORS

11 APPENDIX

• 11.1 DISCUSSION GUIDE
• 11.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 11.3 CUSTOMIZATION OPTIONS
• 11.4 RELATED REPORTS
• 11.5 AUTHOR DETAILS